Zomedica Corp (AMEX: ZOM)’s stock price has plunge by 0.87relation to previous closing price of 0.13. Nevertheless, the company has seen a -0.55% plunge in its stock price over the last five trading sessions. accesswire.com reported 2024-11-27 that ANN ARBOR, MI / ACCESSWIRE / November 27, 2024 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that its Chief Executive Officer, Larry Heaton, will present and host one-on-one meetings with investors at NobleCon20 – Noble Capital Markets’ Twentieth Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, Florida on Wednesday, December 4, 2025 at 11:00 am Eastern Standard Time. A high-definition video webcast of the presentation will be available the following day on the Company’s website, www.zomedica.com, and as part of a complete catalog of presentations available at Noble Capital Markets’ Conference website, www.nobleconference.com, and on the investor portal created by Noble, Channelchek at www.channelchek.com.
Is It Worth Investing in Zomedica Corp (AMEX: ZOM) Right Now?
Additionally, the 36-month beta value for ZOM is 1.06. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ZOM is 962.66M and currently, short sellers hold a 4.95% ratio of that float. The average trading volume of ZOM on December 10, 2024 was 4.77M shares.
ZOM’s Market Performance
The stock of Zomedica Corp (ZOM) has seen a -0.55% decrease in the past week, with a 4.35% rise in the past month, and a 0.16% gain in the past quarter. The volatility ratio for the week is 3.94%, and the volatility levels for the past 30 days are at 5.74% for ZOM. The simple moving average for the past 20 days is -2.66% for ZOM’s stock, with a -9.05% simple moving average for the past 200 days.
Analysts’ Opinion of ZOM
Many brokerage firms have already submitted their reports for ZOM stocks, with Dawson James repeating the rating for ZOM by listing it as a “Buy.” The predicted price for ZOM in the upcoming period, according to Dawson James is $6 based on the research report published on January 06, 2023 of the previous year 2023.
ZOM Trading at -0.39% from the 50-Day Moving Average
After a stumble in the market that brought ZOM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -44.42% of loss for the given period.
Volatility was left at 5.74%, however, over the last 30 days, the volatility rate increased by 3.94%, as shares surge +5.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.15% lower at present.
During the last 5 trading sessions, ZOM fell by -0.55%, which changed the moving average for the period of 200-days by +2.01% in comparison to the 20-day moving average, which settled at $0.1305. In addition, Zomedica Corp saw -36.56% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ZOM starting from Blair Anthony K, who purchase 150,000 shares at the price of $0.12 back on Nov 08 ’24. After this action, Blair Anthony K now owns 400,000 shares of Zomedica Corp, valued at $18,450 using the latest closing price.
POWERS JOHNNY D, the Director of Zomedica Corp, purchase 100,000 shares at $0.12 during a trade that took place back on Nov 11 ’24, which means that POWERS JOHNNY D is holding 2,425,000 shares at $12,100 based on the most recent closing price.
Stock Fundamentals for ZOM
Current profitability levels for the company are sitting at:
- -1.43 for the present operating margin
- 0.55 for the gross margin
The net margin for Zomedica Corp stands at -2.33. The total capital return value is set at -0.19. Equity return is now at value -26.82, with -25.43 for asset returns.
Based on Zomedica Corp (ZOM), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -22.8.
Currently, EBITDA for the company is -29.39 million with net debt to EBITDA at 0.14. When we switch over and look at the enterprise to sales, we see a ratio of 4.37. The receivables turnover for the company is 11.2for trailing twelve months and the total asset turnover is 0.12. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.82.
Conclusion
In conclusion, Zomedica Corp (ZOM) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
